ethacizine

Ethacizine (also known as ethacyzine) is a class Ic antiarrhythmic agent, structurally related to moracizine. It is primarily used in Russia and some other Commonwealth of Independent States (CIS) countries for the management of severe and/or refractory ventricular and supraventricular arrhythmias, particularly those associated with organic heart disease. Ethacizine is also indicated for the treatment of refractory tachycardia linked to Wolff–Parkinson–White syndrome. Its mechanism of action involves blocking cardiac sodium channels, which suppresses retrograde stimulus conduction along the fast pathway of the atrioventricular node, thereby controlling or preventing paroxysms of atrioventricular nodal tachycardia[1][4][6][7]. The drug belongs to the phenothiazines chemical class and is administered orally[2].

Brand names

Ethacizin

Other names

ethacyzineethacizine hydrochloride